trial · primary record
TYRA-300 60mg
Low-grade NMIBC
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 90 |
| Primary completion | 2028-09 |
| Primary endpoint | To assess the efficacy of TYRA-300 in LG IR-NMIBC participants |
| Registry ID | NCT06995677 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:19.766Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06995677
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.